BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17572583)

  • 1. Dextran 40 therapy made safer by pretreatment with dextran 1.
    Ljungström KG
    Plast Reconstr Surg; 2007 Jul; 120(1):337-340. PubMed ID: 17572583
    [No Abstract]   [Full Text] [Related]  

  • 2. Pretreatment with dextran 1 makes dextran 40 therapy safer.
    Ljungström KG
    J Vasc Surg; 2006 May; 43(5):1070-2. PubMed ID: 16678710
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety of dextran in relation to other colloids--ten years experience with hapten inhibition.
    Ljungström KG
    Infusionsther Transfusionsmed; 1993 Oct; 20(5):206-10. PubMed ID: 7508309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risks of infusion of colloidal solutions].
    Messmer K
    Infusionsther Transfusionsmed; 1993 Dec; 20(6):284-5. PubMed ID: 7511447
    [No Abstract]   [Full Text] [Related]  

  • 5. Hapten inhibition of dextran anaphylaxis. Nine years of post-marketing surveillance of dextran 1.
    Ljungström KG; Willman B; Hedin H
    Ann Fr Anesth Reanim; 1993; 12(2):219-22. PubMed ID: 7690207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Severe dextran-induced anaphylactic/anaphylactoid reaction despite preventive hapten administration].
    Allhoff T; Lenhart FP
    Infusionsther Transfusionsmed; 1993 Dec; 20(6):301-6. PubMed ID: 7511449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of dextran anaphylaxis].
    Laubenthal H; Peter K; Messmer K
    MMW Munch Med Wochenschr; 1982 Oct; 124(43):951-3. PubMed ID: 6183584
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention of allergic dextran reactions by premedication of 20 ml hapten in 12,000 patients in Switzerland].
    Gruber UF; Wettler H; Allemann U; Gerber H; Laubenthal H; Messmer K
    Schweiz Rundsch Med Prax; 1983 Feb; 72(8):269-70. PubMed ID: 6188142
    [No Abstract]   [Full Text] [Related]  

  • 9. Hapten inhibition and dextran anaphylaxis.
    Ljungström KG; Renck H; Hedin H; Richter W; Wiholm BE
    Anaesthesia; 1988 Sep; 43(9):729-32. PubMed ID: 2459986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathomechanisms of dextran-induced anaphylactoid/anaphylactic reactions in man.
    Hedin H; Richter W
    Int Arch Allergy Appl Immunol; 1982; 68(2):122-6. PubMed ID: 6176555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of dextran-induced anaphylactoid reactions by hapten inhibition.
    Messmer K; Ljungstrom KG; Gruber UF; Richter W; Hedin H
    Lancet; 1980 May; 1(8175):975. PubMed ID: 6154846
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of dextran-induced anaphylactic reactions by hapten inhibition. II. A comparison of the effects of 20 ml dextran 1, 15%, administered either admixed to or before dextran 70 or dextran 40.
    Renck H; Ljungström KG; Rosberg B; Dhunér KG; Dahl S
    Acta Chir Scand; 1983; 149(4):349-53. PubMed ID: 6193666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Macrodex/Rheomacrodex. Prevention of adverse effects].
    Ljungström KG; Ulseth E; Lilleaasen P
    Tidsskr Nor Laegeforen; 1986 Jan; 106(2):129-31. PubMed ID: 2420021
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of dextran-induced anaphylactic reactions by hapten inhibition. III. A Scandinavian multicenter study on the effects of 20 ml dextran 1, 15%, administered before dextran 70 or dextran 40.
    Renck H; Ljungström KG; Hedin H; Richter W
    Acta Chir Scand; 1983; 149(4):355-60. PubMed ID: 6193667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of dextran anaphylaxis using hapten dextran].
    Comberg HU
    Dtsch Med Wochenschr; 1984 Jan; 109(1):36-8. PubMed ID: 6198137
    [No Abstract]   [Full Text] [Related]  

  • 16. Activation of complement in anaphylactoid reactions in connection with infusion of dextran.
    Johnson U; Laurell AB
    Scand J Immunol; 1974; 3(5):673-6. PubMed ID: 4214504
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anaphylactoid reactions after dextran II. Experimental studies in animals on the principle of hapten inhibition].
    Messmer K; Seemann C; Richter W; Hedin H; Laubenthal H
    Beitr Infusionther Klin Ernahr; 1981; 8():66-81. PubMed ID: 6172112
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of dextran anaphylaxis. Ten years experience with hapten dextran.
    Hedin H; Ljungström KG
    Int Arch Allergy Immunol; 1997; 113(1-3):358-9. PubMed ID: 9130577
    [No Abstract]   [Full Text] [Related]  

  • 19. Anaphylactoid reactions to Dextran 40 and 70: reports to the United States Food and Drug Administration, 1969 to 2004.
    Zinderman CE; Landow L; Wise RP
    J Vasc Surg; 2006 May; 43(5):1004-9. PubMed ID: 16678697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of dextran-induced anaphylactic reactions by hapten inhibition. I. A Scandinavian multicenter study on the effects of 10 ml dextran 1, 15% administered before dextran 70 or dextran 40.
    Ljungström KG; Renck H; Hedin H; Richter W; Rosberg B
    Acta Chir Scand; 1983; 149(4):341-8. PubMed ID: 6193665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.